Policy Issue

House of Representatives

Senate

Telehealth Extension

House Energy and Commerce Committee:

H.R. 7858, Telehealth Enhancement for Mental Health Act of 2024

– Reported out on 05/16/24

House Ways and Means Committee:

H.R. 8261, Preserving Telehealth, Hospital and Ambulance Access Act

– Reported out on 05/08/24

H.R. 1843, Telehealth Expansion Act of 2023

– Reported out on 06/13/23

Senate HELP Committee:

S. 644, Modernizing Opioid Treatment Access Act

– Reported out on 02/01/24

PBM Reform

House Energy and Commerce Committee:

H.R. 2880, Protecting Patients Against PBM Abuses Act

– Reported out on 12/06/23

H.R. 3561, PATIENT Act of 2023

– Reported out on 05/24/23

H.R. 5393, To amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy
performance and quality under Medicare Part D and for other purposes

– Reported out on 12/06/23

H.R. 5385, Medicare PBM Accountability Act

– Reported out on 12/06/23

H.R. 5378, Lower Costs, More Transparency Act

– Passed the House on suspension calendar on 12/11/23

Senate Finance Committee:

S. 2973, Modernizing and Ensuring PBM Accountability Act

– Reported out on 12/07/23

Senate Commerce, Science and Transportation Committee:

S. 127, Pharmacy Benefit Manager Transparency Act of 2023

– Reported out on 12/13/23

Senate HELP Committee:

S. 1339, Pharmacy Benefit Manager Reform Act

– Reported out on 05/11/23

Senate Judiciary Committee:

S. 113, Prescription Pricing for the People Act of 2023

– Reported out on 03/01/23

Insulin $35 Cap

Senate HELP Committee:

S. 146, Cap Insulin Prices Act

– Referred to committee on
01/30/23

S. 727, Insulin for All
Act of 2023

– Referred to committee on 03/09/23

S. 1269, Improving
Needed Safeguards for Users of Lifesaving Insulin Now Act of 2023

– Referred to committee on
04/25/23

S. 954, Affordable Insulin Now Act of 2023

– Referred to committee on
03/23/23

Drug Patent Reform

Senate Judiciary Committee:

S. 79, Interagency Patent Coordination and Improvement Act of 2023

– Reported out on 03/01/23

S. 142, Preserve Access to Affordable Generics and Biosimilars Act

– Reported out on 02/09/23

S. 148, Stop STALLING Act

– Reported out on 02/09/23

S. 150, Affordable Prescriptions for Patients Act of 2023

– Reported out on 02/09/23

– Passed the Senate on 07/11/24

BIOSECURE Act

House Committee on Oversight and Accountability:

H.R. 7085, BIOSECURE Act

– Referred to committee on 01/25/24

H.R. 8333, BIOSECURE Act

– Reported out on 05/15/24

Senate Homeland Security and Governmental Affairs Committee:

S. 3558, Prohibiting Foreign Access to American Genetic Information Act of 2024

– Reported out on 03/06/2024

Medicaid

House Energy and Commerce Committee:

H.R. 8112, To amend title XIX of the Social Security Act to further require certain additional
provider screening under the Medicaid program

– Reported out on 06/12/24

H.R. 8111, Medicaid Program Improvement Act

– Reported out on 06/12/24

H.R. 8089, Medicare and Medicaid Fraud Prevention Act of 2024

– Reported out on 06/12/24

H.R. 4758, Accelerating Kids’ Access to Care Act

– Reported out on 06/12/24

H.R. 3836, Medicaid Primary Care Improvement Act

– Reported out on 09/01/23

– Passed the House on 03/05/24

H.R. 2666, Medicaid VBPs for Patients Act

– Reported out on 05/24/23

H.R. 485, Protecting Health Care for All Patients Act of 2023

– Reported out on 03/24/23

– Passed the House on 02/07/24

H.R. 4531, Support for Patients and Communities Reauthorization Act

– Reported out on 07/19/23

– Passed the House on
12/12/23

House Energy and Commerce Committee Subcommittee on Health:

H.R. 7573, Stop Unfair Medicaid Recoveries Act

– No action yet

Senate Finance Committee:

S. 3430, Better Mental Health, Lower-Cost Drugs and Extenders Act of 2023

– Reported out on 12/07/23

Transparency

House Ways and Means Committee:

H.R. 4822, Health Care Price Transparency Act of 2023

– Reported out on 09/29/23

H.R. 8816, American Medical Innovation and Investment Act of 2024

– Reported out on 06/27/24

House Energy and Commerce Committee:

H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and
oversight of the 340B drug discount program

– Reported out on 05/24/23

H.R. 5378, Lower Costs, More Transparency Act

– Passed the House on suspension calendar on 12/11/23

H.R. 3561, PATIENT Act of 2023

– Reported out on 05/24/23

H.R. 5393, To amend title XVIII of the Social Security Act to ensure fair
assessment of pharmacy performance and quality under Medicare part D, and for
other purposes

– Reported out on 12/06/23

Senate HELP Committee:

S. 2840, Bipartisan Primary Care and Health Workforce Act

– Reported out on 11/08/23

Site-Neutral Payments

House Energy and Commerce Committee:

H.R. 3561, PATIENT Act of 2023

– Reported out on 05/24/23

H.R. 5378, Lower Costs, More Transparency Act

– Passed the House on suspension calendar on 12/11/23

House Ways and Means Committee:

H.R. 4822, Health Care Price Transparency Act of 2023

– Reported out on 09/29/23

Restore Medicare Physician-Fee Schedule Cuts

Senate Finance Committee:

04/11/24: Committee held hearing concerning Medicare PFS Cuts

05/17/24: Committee released a white paper on physician payment reform

340B

House Energy and Commerce Committee:

H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.

– Reported out on 05/24/23

H.R. 8574, 340B Affording Care for Communities and Ensuring a Strong Safety-net Act

– Referred to committee on 05/28/24

House Energy and Commerce Committee Subcommittee on Health:

H.R. 7635, The 340B PATIENTS Act of 2024

– Referred to subcommittee on 03/15/24

Senate HELP Committee:

S. 1133, 340B Accountability Act of 2023

– Referred to committee on 03/30/23

S. 1182, 340B Reporting and Accountability Act

– Referred to committee on 04/18/23